Lead sponsor
Purdue University
1 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 6, 2026.
1
Trials led
0
Ongoing
90
Total enrollment
1
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Not applicable
1
Trials by status
Completed
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
The Effects of GLP-1 Receptor Agonists on Chemosensory Function and Ingestive BehaviorBMI ≥30not applicableCompleted90